Use of nitric-oxide-eluting polymer-coated coronary stents for prevention of restenosis in pigs

Coronary Artery Disease

Volumn 11, Issue 4, 2000, Pages 351-357

  Buergler, John M ^a   Tio, Fermin O ^b   Schulz, Daryl G ^a   Khan, Musa M ^a   Mazur, Wojciech ^a   French, Brent A ^a   Raizner, Albert E ^a   Ali, Nadir M ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Animal model; Nitric oxide

Indexed keywords

COLLAGEN; NITRIC OXIDE; POLYMER; TANTALUM;

ANGIOGRAPHY; ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY STENT; DEVICE; HISTOLOGY; INFLAMMATORY CELL; INTIMA; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE SPASM; SWINE; THROMBOCYTE AGGREGATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY DISEASE; NITRIC OXIDE; RECURRENCE; STENTS; SWINE; SWINE, MINIATURE;

EID: 0034131147     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200006000-00009     Document Type: Article

References (37)

1. 1 Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84:1426-1436.
2. 2 Beatt KJ, Serruys PW, Hugenholtz PG. Restenosis after coronary angioplasty: new standards for clinical studies. J Am Coll Cardiol 1990; 15:491-498.
3. 3 Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 1995; 25:516-520.
4. 4 Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331:489-495.
5. 5 Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331:496-501.
6. 6 Culotta E, Koshland DE. NO new is good news. Science 1992; 258:1862-1865.
7. 7 Gonzales C, Fernandez A, Mortin C. Nitric oxide from endothelium and smooth muscle modulates response to sympathetic nerve stimulation: implications for endotoxin shock. Biochem Biophys Res Commun 1992; 186:150-156.
8. 8 Corbett JA, McDaniel ML. Does nitric oxide mediate autoimmune destruction of B-cells? Possible therapeutic interventions in IDDM. Diabetes 1992; 41:898-903.
9. 9 Parkinson JF, Mitrovic B, Merrill JE. The role of nitric oxide in multiple sclerosis. J Mol Med 1997; 75:174-186.
10. 10 Shimokawa H, Vanhoutte PM. Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries. J Am Coll Cardiol 1989; 13:1402-1408.
11. 11 Murad F. What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle. Circulation 1997; 95:1101-1103.
12. 12 Garg UC, Hassid A. Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. Eur J Pharmacol 1993; 237:243-249.
13. 13 Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 1995; 25:674-678.
14. 14 Diodati JG, Quyyumi AA, Hussain N, Keefer LK. Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: antiplatelet effect. Thromb Hemost 1993; 70:654-658.
15. 15 Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987; 90:687-692.
16. 16 Alheid U, Frolich JC, Forstermann U. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res 1987; 47:561-566.
17. 17 Lablanche JM, Grollier G, Lusson JR, Bassand JP, Drobinski G, Bertrand B, et al. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem. Circulation 1997; 95:83-89.
18. 18 Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, et al. Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. Circulation 1988; 77:361-371.
19. 19 Vanderford PA, Wong J, Chang R, Keefer LK, Soifer SJ, Fineman JR. Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs. J Cardiovasc Pharmacol 1994; 23:113-119.
20. 20 Morley D, Keefer LK. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators [review]. J Cardiovasc Pharmacol 1993; 22 (suppl 7)S3-S9.
21. 21 Morley D, Maragos CM, Zhang XY, Boignon M, Wink DA, Keefer LK. Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. J Cardiovasc Pharmacol 1993; 21:670-676.
22. 22 Diodati JG, Quyyumi AA, Keefer LK. Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: hemodynamic effect in the rabbit. J Cardiovasc Pharmacol 1993; 22:287-292.
23. 23 Maragos CM, Wang JM, Hrabie JA, Oppenheim JJ, Keefer LK. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res 1993; 53:564-568.
24. 24 Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, et al. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 1991; 34:3242-3247.
25. 25 Folts JD, Maalej N, Keaney JF, Loscalzo J. Palmaz-Schatz stents coated with a NO donor reduce reocclusion when placed in pig carotid arteries for 28 days [abstract]. J Am Coll Cardiol 1996; 27.
26. 26 Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up. J Am Coll Cardiol 1995; 25:1451-1456.
27. 27 Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, Holmes DR. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 1990; 82:2190-2200.
28. 28 Ali MM, Mazur W, Kleiman NS, Rodgers GP, Abukhalil JM, French BA, et al. Inhibition of coronary restenosis by antithrombin III in atherosclerotic swine. Coronary Artery Dis 1996; 7:851-861.
29. 29 van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DRJ, et at. Marked inflammatory sequelae to implantation of biodegradable and non-biodegradable polymers in porcine coronary arteries. Circulation 1996; 94:1690-1697.
30. 30 Fischell TA. Polymer coatings for stents. Can we judge a stent by its cover? Circulation 1996; 94:1494-1495.
31. 31 Peng T, Gibula P, Yao KD, Goosen MF. Role of polymers in improving the results of stenting in coronary arteries [review]. Biomaterials 1996; 17:685-694.
32. 32 De Scheerder IK, Wilczek KL, Verbeken EV, Vandorpe J, Lan PN, Schacht E, et al. Biocompatibility of biodegradable and non-biodegradable polymer-coated stents implanted in porcine peripheral arteries. Cardiovasc Interventional Radiol 1995; 18:227-232.
33. 33 De Scheerder IK, Wilczek KL, Verbeken EV, Vandorpe J, Lan PN, Schacht E, et al. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis 1995; 114:105-114.
34. 34 van Beusekom HM, Serruys PW, van der Giessen WJ. Coronary stent coatings [review]. Coronary Artery Dis 1995; 5:590-596.
35. 35 Tanguay JF, Zidar JP, Phillips HR, Stack RS. Current status of biodegradable stents [review]. Cardiol Clin 1994; 12:699-713.
36. 36 Holmes DR, Camrud AR, Jorgenson MA, Edwards WD, Schwartz RS. Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents. J Am Coll Cardiol 1994; 24:525-531.
37. 37 de Scheerder I, Wang K, Wilczek K, van Dorpe J, Verbeken E, Desmet W, et al. Local methylprednisolone inhibition of foreign body response to coated intracoronary stents. Coronary Artery Dis 1996; 7:161-166.